Research Article
Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System
Table 2
Base-case costs estimates ($, year 2013 values) and utilities.
| Parameter | Median | Range | Description and reference |
| Costs | | | | Cost of 425 mg of apatinib | 106.5 | 53.2~106.5 | Local charge | Cost of palliative care in end of life | 1483.9 | 1072.3~2119.3 | Calculation | Cost of supportive care per cycle | 117.1 | 32.3~322.6 | Calculation | Utilities& | | | | Utility of disease-free | 0.88 | 0.8~0.97 | Measured | Utility of recurrent disease | 0.41 | 0.28~0.63 | Measured |
|
|
&The values were measured by the time trade-off (TTO).
|